Program
The presentation of the 2022 BioRegion Report took place on February 13, 2023. The document compiles the main innovation indicators and macroeconomic data on the life sciences and healthcare sector in Catalonia, updated in December 2022, including investment numbers.
Morning sessions
Mr. Pere Aragonès i Garcia, President of the Government of Catalonia
Robert Fabregat, Biocat CEO
- Mariona Serra, Vice-president of CataloniaBio & HealthTech and CEO of GoodGut
- Pedro Luis Sánchez, Director of the Studies Department at Farmaindustria
- Carles Sisternas, Director of Fenin Catalonia
Moderated by: Lluís Rovira, Director of CERCA Institute (Research Centers of Catalonia)
- Anton Ussi, Director of Operations and Finance at EATRIS ERIC
- Josep Maria Martorell, Deputy Director of the Barcelona Supercomputing Center (BSC)
- Mònica Bayès, Strategy Coordinator at the National Center for Genomic Analysis (CNAG)
- Caterina Biscari, Director of the Alba Synchrotron
Moderated by: Ramon Maspons, Chief Health Innovation Strategist for the Catalan Ministry of Health
- Fina Lladós, General Manager of Amgen Spain and Portugal
- Chus Castillo, Vice-president of Market Access Iberia at ALIRA HEALTH
- Laura Sampietro, Chair of the AQuAS Board of Directors and Deputy Director of Innovation at Hospital Clinic Barcelona
- Lluís Juncà, Director General for Innovation, Digital Economy and Entrepreneurship for the Government of Catalonia
Moderated by: Francisco Lupiáñez, UOC Professor of Information and Communication Sciences
- Montserrat Daban, Biocat Director of Science Policy and Internationalization
- Jordi Piera, Director of the Digital Health Strategy Office at the Catalan Health Service
- Sven Parkel, Secretary General of Scan Balt and Board Member at Connected Health, Estonia
- Michel Silvestri, Head of Unit at the Coordination Department of the Swedish eHealth Agency
Moderated by: Núria Martí, Biocat Director of Innovation and Business Development
- Robert Fabregat, Biocat CEO
- Andreu Mas-Colell, President of the Board of Directors at the Blood and Tissue Bank
- Ion Arocena, AseBio CEO
- Cristina Nadal, Executive Policy Director, MSD - Merck Sharp & Dohme Spain
Mr. Manel Balcells i Díaz, Catalan Minister of Health
Afternoon sessions
Szabolcs Szekacs, Digital Industry Team Leader, European Commission, DG Growth
Moderated by: Montserrat Daban, Biocat Director of Science Policy and Internationalization
- Björn Arvidsson, Managing Director of STUNS Life Sciences (Sweden)
- Sohail Nourestani, E-Health Consultant of Eurasanté
- Sven Parkel, Secretary General of Scan Balt and Board Member at Connected Health, Estonia
- Szabolcs Szekacs, Digital Industry Team Leader, European Commission, DG Growth
Moderated by: Javier Selva, Catalonia Bio & Health Tech CEO
- Karen Lindegaard, International Program Manager of the Danish Life Sciences Cluster
- Antonio Novo, President of the European Clusters Alliance (Brussels)
- Olga Trofymova, Ukrainian Clusters Alliance
- Marek Przeor, European Commission Team Leader for Cluster Policy
Moderated by: Anaïs LeCorvec, Director of the Council of European BioRegions
- Tero Piispanen, Senior Executive at HealthTurku, Turku Science Park (Finland)
- Alexandra Patriksson, Science Relations Manager at Testa Center (Sweden)
- Ángeles Barrios, Public Affairs and Stakeholder Relations at EIT Health, Spain
Laura Roman, Industry 5.0 Policy Officer, European Commission
Robert Fabregat, CEO, Biocat